(Harrisburg, Pa.) A Report that was released by the State of Pennsylvania on Tuesday, July 28, 2020, stated that 205 of the 435 residents Patients at Brighton Rehab and Wellness Center were given the experimental drug hydroxychloroquine without approval from the Pennsylvania Department of Health. This is the same drug that President Trump has been pushing for use of for the COVID-19 but the FDA says that in Clinical Trials it has not been proven as an effective treatment for COVID-19.

Brighton Rehab and Wellness has been a hot spot for the virus in the state. As of yesterday, July 28, 2020 there have been 332 resident cases and 73 deaths attributed to the COVID-19 at the facility. There have also been 113 employee cases of the virus. The facility has a total of 589 beds with 314 people currently residing there.